Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 1 4Phase 1/2 3Phase 2 2

Status

Completed 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 576Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 177pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117lenvatinib 107camrelizumab 107Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × napabucasin × Gastrointestinal × Clear all
NCT01776307 2023-11-15

A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

Sumitomo Pharma America, Inc.

Phase 2 Completed
200 enrolled 23 charts
Gastrointestinal

Colorectal Neoplasms

NCT03647839 2021-08-27

MODULATE

Australasian Gastro-Intestinal Trials Group

Phase 2 Completed
90 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡